文献速递乳腺癌放疗

老年I期雌激素受体阳性乳腺癌辅助放疗与心脏死亡风险的关联:基于SEER的研究

The Association Between Cardiac Mortality and Adjuvant Radiation Therapy Among Older Patients With Stage I Estrogen Positive Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Study on Cardiac Mortality and Radiation Therapy.
PubMed 文献 · Adv Radiat Oncol · 2020-12-03

该研究利用2000至2015年SEER数据库,纳入60岁及以上接受保乳手术和放疗的I期雌激素受体阳性乳腺癌患者,评估辅助放疗、肿瘤侧别与心脏特异性生存(CSS)的关联。中位随访6年,左侧与右侧乳腺癌患者的5年和10年CSS无差异,多因素分析亦未发现肿瘤侧别或象限位置与CSS、乳腺癌特异性生存或总生存相关。结论认为现代放疗技术下老年左侧乳腺癌患者未增加心脏死亡风险。

要点

  • 左侧与右侧乳腺癌放疗后5年CSS分别为98.3%与98.2%,10年分别为94.3%与93.9%,无统计学差异。
  • 调整后肿瘤侧别与5年CSS、乳腺癌特异性生存及总生存均无关联。
  • 内象限与外象限位置对左右侧乳腺癌的5年CSS均无显著影响。

核心结论

  • 现代放疗技术下,老年左侧I期雌激素受体阳性乳腺癌患者接受辅助放疗后心脏死亡风险未较右侧患者增加。

研究设计与样本

  • 基于2000至2015年SEER数据库的回顾性人口队列研究,纳入60岁及以上接受保乳手术和放疗的I期雌激素受体阳性乳腺癌患者。

主要发现

  • 调整后肿瘤侧别与5年CSS无关联(HR=0.96,95%CI 0.87-1.06),与乳腺癌特异性生存(HR=0.96,95%CI 0.85-1.09)及总生存(HR=0.98,95%CI 0.94-1.03)亦无关联。
  • 内象限与外象限位置对右侧乳腺癌调整后5年CSS无关联(HR=1.06,95%CI 0.89-1.12),对左侧乳腺癌亦无关联(HR=0.95,95%CI 0.79-1.15)。

临床怎么用

  • 对于60岁及以上I期雌激素受体阳性乳腺癌患者,可提供辅助放疗而不必担心诱发心脏相关死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated the risk of cardiac mortality in older patients who receive adjuvant radiation therapy (RT) for stage I breast cancer to determine whether this risk persists in the modern era. METHODS AND MATERIALS: Using the 2000 to 2015 Surveillance, Epidemiology, and End Results program data, we performed a population-based cohort study to evaluate the association between adjuvant breast RT, tumor laterality, and cardiac-specific survival (CSS) among patients 60 and older with stage I estrogen receptor positive breast cancer who received breast-conserving surgery and RT. RESULTS: At a median follow-up of 6 years (range, 0-15.9 years), patients receiving RT for left-sided breast cancer demonstrated no difference in 5- and 10-year CSS compared with those with right-sided breast cancer (5 year 98.3% vs 98.2%, 10 year 94.3% vs 93.9%; log-rank P = .56). Cox proportional hazards regression analysis confirmed the lack of association of tumor laterality on adjusted 5-year CSS (hazard ratio [HR] = 0.96; 95% confidence interval [CI] = 0.87-1.06), breast-cancer specific survival (HR = 0.96; 95% CI = 0.85-1.09), and overall survival (HR = 0.98; 95% CI = 0.94-1.03). There was also no association of inner versus outer quadrant location on adjusted 5-year CSS for right-sided (HR = 1.06; 95% CI = 0.89-1.12) and left-sided breast cancer (HR = 0.95; 95% CI = 0.79-1.15). CONCLUSIONS: With modern radiation therapy techniques, older patients who received left-sided RT for stage I estrogen-receptor positive breast cancer do not demonstrate an increased risk of cardiac mortality compared with patients with right-sided breast cancer. RT can be offered to older patients without concern for inducing cardiac-related death.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Jimenez RB, Wong SM, Johnson A, et al. The Association Between Cardiac Mortality and Adjuvant Radiation Therapy Among Older Patients With Stage I Estrogen Positive Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Study on Cardiac Mortality and Radiation Therapy. Adv Radiat Oncol. 2020. PMID: 33912735. doi:10.1016/j.adro.2020.100633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。